DRIVE Project

A research project aimed at increasing awareness and understanding of influenza vaccine effectiveness.
Funded by @IHIEurope

[DRIVE Project @drive_eu]

DRIVE's final video: our take-home messages

Learn about what we have done in the last 5 years with @drive_eu project, funded by @IHIEurope

https://t.co/YwQXrhQ2lP

[DRIVE Project @drive_eu]

Our latest publication "Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies: Experience from the DRIVE project" is now online in the Influenza and Other Respiratory Virus journal.

More information: https://t.co/oTViPFJU2A

[Área de Investigación en Vacunas @AIVFisabio]

📚Disponibles nuevos resultados de @drive_eu.

La publicación apoya el uso de las variables #edad, #sexo y tiempo de calendario en el ajuste de los factores de confusión de los estudios de efectividad de la 💉de la #gripe con diseño de test negativo.

https://t.co/Ejox4z2g9D

[SYNAPSE R&D Managers @SynapseManagers]

Elena del Rey, our Business Development & Services Manager, participates as co-author in this article for her involvement in the management and conceptualization of @drive_eu

Read full article ⬇️
https://t.co/7D4xMtKmhs

[DRIVE Project @drive_eu]

New DRIVE publication / Nueva publicación de DRIVE

[Área de Investigación en Vacunas @AIVFisabio]

Publicación | Las asociaciones público-privadas han demostrado desempeñar un papel fundamental en el estudio de las enfermedades infecciosas📚🦠💉

➡️En este artículo, el equipo @drive_eu, explica el valor de este tipo de plataformas y su experiencia.

https://t.co/lsOAehBuFI

[DRIVE Project @drive_eu]

The synopsis is the appetizer to our manuscript "The value of public-private collaborative Real-World Evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative" which will be published in Expert Reviews of Vaccines in the coming days.

[DRIVE Project @drive_eu]

Last week we released a synopsis of the DRIVE Project main accomplishments and key lessons learnt.

You can find it in our website: https://t.co/8BbgrTOXzv

[Charlotte Vernhes @CCVernhes]

I want to amplify the great achievements from the @drive_eu IMI project. Through a transparent collaboration framework, they were able to build a large network of study sites in 7 European countries, to generate brand-specific influenza vaccine estimates [1/2]

[DRIVE Project @drive_eu]

After a long break, the DRIVE partners will meet again on the 13th of October to discuss the ongoing activities and our next steps 🤝💉

#influenza #vaccines #postDRIVE #IHI

[Área de Investigación en Vacunas @AIVFisabio]

Vídeo | Estamos felices de presentar este vídeo📹 recopilatorio del trabajo de nuestro proyecto @drive_eu a lo largo de sus 5⃣ años de vida y sus frutos.

➡️ Objetivos, asociación público-privada, resultados y futuros pasos.

¡Esperamos que lo disfrutéis!
https://t.co/QxgeVIlpBP

[Innovative Health Initiative @IHIEurope]

IMI project @drive_eu developed a platform for monitoring #flu #vaccine effectiveness… and adapted it to monitor #COVID19 vaccines…
https://t.co/WBa6L2yHm9

[Charlotte Vernhes @CCVernhes]

We're joined by my colleague Laurence Pagnon sharing lessons learned from public private partnerships for influenza and COVID-19 vaccine evaluation @drive_eu and covidrive @IHIEurope @RESCEUproject

[DRIVE Project @drive_eu]

DRIVE Project bids farewell after 5 prolific years.
2021/2022 results report was officially submitted to the @IHIEurope and @EMA_News and it is now available on the DRIVE website.

https://t.co/0JFbosqdCT

[DRIVE Project @drive_eu]

DRIVE officially ended under the Innovative Medicines Initiative (IMI) umbrella on the 30th of June 2022. With this final post, DRIVE consortium partners would like to bring the curtain down to an equally challenging and enriching project.
https://t.co/1H2QOcyJst

[DRIVE Project @drive_eu]

On 8 June 2022, as part of its final Annual Forum, @drive_eu hosted a public roundtable bringing together key European stakeholders, including public institutions’ representatives, to discuss the initiative’s results after five prolific years.
https://t.co/2fyIyIbWRk

[DRIVE Project @drive_eu]

The DRIVE Project bids farewell after 5 prolific years with its final Annual Forum, which took place in Brussels (and virtually) on the 8th of June, 2022. https://t.co/kDc6sYnIEa

[DRIVE Project @drive_eu]

As part of our final #AnnualForum, we were pleased to host a public roundtable bringing together main European stakeholders to discuss our 5-year achievements.
Thanks to Marco Cavaleri (@EMA_News), @HNohynek (@THLorg) and @sibiliaquilici (@VaccinesEurope)

https://t.co/02Oj489NrH

[Elisa Martró @ElisaMartro]

The #CanRuti team on behalf of @hgermanstrias @GTRecerca enjoying the @drive_eu @IMI_JU @EU_Commission annual forum

@mseguramalavez @ValeraJulia @SaludesVeronica & Beatriz Blanco

#Influenza #SARSCoV2 #vaccine #effectiveness

[DRIVE Project @drive_eu]

DRIVE Annual Forum 2022 is over.
Thank you so much for your interest and keep tuned for more information on #influenza and #covid19 #vaccine #effectiveness

@drive_eu web and social media team: @ClaudiaRavaldi @Quentin79 @AlfVann

[DRIVE Project @drive_eu]

After 5 prolific years, DRIVE, as an Innovative Medicines Initiative (@IHIEurope) project, comes to an end. The final DRIVE Annual Forum has now started.

@javierdiezd and @_CedricMahe_ are introducing SESSION 1 - Public Roundtable on the benefits of Public-Private Partnership

[DRIVE Project @drive_eu]

And finally the closing plenary session on #COVIDRIVE: Leveraging influenza platform to tackle COVID-19 pandemic.
Antonio Carmona (@GVAfisabio ) and Kaatje Bollaerts (@P95) present first COVID-19 vaccine effectiveness study.